S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30

Danaher Stock Forecast, Price & News

-3.59 (-1.28%)
(As of 01/24/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
5.53 million shs
Average Volume
3.57 million shs
Market Capitalization
$197.84 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

Danaher logo

About Danaher

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.


Danaher Enters Oversold Territory (DHR) - Nasdaq
January 24, 2022 |  nasdaq.com
Price To Earnings Ratio Insights For Danaher
January 24, 2022 |  benzinga.com
Danaher (DHR) Stock Moves -0.48%: What You Should Know
January 19, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Process control instruments
Industrial Conglomerates
Year Founded

Sales & Book Value

Annual Sales
$22.28 billion
Cash Flow
$9.32 per share
Book Value
$51.39 per share


Net Income
$3.65 billion
Pretax Margin




Free Float
Market Cap
$197.84 billion

Company Calendar

Ex-Dividend for 10/29 Dividend
Last Earnings
Dividend Payable
Ex-Dividend for 1/28 Dividend
Next Earnings (Confirmed)
Dividend Payable
Fiscal Year End

Social Links


Overall MarketRank

2.78 out of 5 stars

Multi-Sector Conglomerates Sector

5th out of 26 stocks

Process Control Instruments Industry

2nd out of 17 stocks

Analyst Opinion: 2.5Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 1 hold rating and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher
or view top-rated stocks.

How has Danaher's stock price been impacted by Coronavirus?

Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 98.7% and is now trading at $276.86.
View which stocks have been most impacted by COVID-19

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Danaher

How can I listen to Danaher's earnings call?

Danaher will be holding an earnings conference call on Thursday, January 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) posted its earnings results on Wednesday, October, 20th. The conglomerate reported $2.39 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.15 by $0.24. The conglomerate earned $7.20 billion during the quarter, compared to analysts' expectations of $7 billion. Danaher had a trailing twelve-month return on equity of 18.32% and a net margin of 20.97%. Danaher's quarterly revenue was up 22.0% on a year-over-year basis. During the same period last year, the firm earned $1.72 EPS.
View Danaher's earnings history

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Tuesday, December 7th. Investors of record on Thursday, December 30th will be paid a dividend of $0.21 per share on Friday, January 28th. This represents a $0.84 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Wednesday, December 29th.
View Danaher's dividend history

Is Danaher a good dividend stock?

Danaher pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.30%. Danaher has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Danaher is 10.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 8.18% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.

What price target have analysts set for DHR?

14 brokers have issued 12 month price targets for Danaher's shares. Their forecasts range from $290.00 to $370.00. On average, they expect Danaher's stock price to reach $344.54 in the next year. This suggests a possible upside of 24.4% from the stock's current price.
View analysts' price targets for Danaher
or view top-rated stocks among Wall Street analysts.

Who are Danaher's key executives?

Danaher's management team includes the following people:

What is Rainer M. Blair's approval rating as Danaher's CEO?

27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (0.11%), Intermede Investment Partners Ltd (0.11%), New York State Teachers Retirement System (0.10%), Russell Investments Group Ltd. (0.10%), Strs Ohio (0.07%) and Retirement Systems of Alabama (0.06%). Company insiders that own Danaher stock include Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Elias A Zerhouni, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Intermede Investment Partners Ltd, Moody National Bank Trust Division, Gulf International Bank UK Ltd, Parallel Advisors LLC, Riverbridge Partners LLC, Royal London Asset Management Ltd., and Retirement Systems of Alabama. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel Raskas, Elias A Zerhouni, Joakim Weidemanis, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Robert S Lutz, Teri List, and Walter G Lohr.
View insider buying and selling activity for Danaher
or view top insider-selling stocks.

Which institutional investors are buying Danaher stock?

DHR stock was acquired by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Vaughan Nelson Investment Management L.P., Stonnington Group LLC, Russell Investments Group Ltd., Huntington National Bank, Sumitomo Mitsui DS Asset Management Company Ltd, Aries Wealth Management, and Miracle Mile Advisors LLC.
View insider buying and selling activity for Danaher
or or view top insider-buying stocks.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $276.86.

How much money does Danaher make?

Danaher has a market capitalization of $197.84 billion and generates $22.28 billion in revenue each year. The conglomerate earns $3.65 billion in net income (profit) each year or $7.89 on an earnings per share basis.

How many employees does Danaher have?

Danaher employs 69,000 workers across the globe.

Does Danaher have any subsidiaries?

The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima KK, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Finance ApS, Beckman Holdings Ltd., BioTector Analytical Systems Ltd, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., ChemTreat International Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology (Guangzhou) Co. Ltd., Cytiva Biotechnology (Hang Zhou) Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, Cytiva Sweden Holding AB, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Japan Finance Sarl, DH Life Sciences LLC, DH Netherlands BV, DH Technologies Development Pte Ltd., DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher (Shanghai) Management Co. Ltd., Danaher Hong Kong Limited, Danaher Medical ApS, Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Finance BV, Esko Graphics BV, Esko Software BV, FHAB Company AB, Fluke, G. Lufft Mess- und Regeltechnik GmbH, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions New Zealand, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies (Shanghai) Co Ltd., Global Life Sciences Technologies Japan KK, Hach Company, Hach Lange Finance GmbH, Hach Lange GmbH, Hach Lange Sàrl, Hach Sales & Services Canada LP, Hach Ultra Japan KK, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Iris International Inc., Joslyn Holding Company LLC, KVHG GmbH, KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS*, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Microtest, Molecular Devices, Molecular Devices (Austria) GmbH, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nihon Pall Manufacturing Limited, Nobel Biocare, OTT Hydromet Corp, Pall, Pall (Canada) ULC, Pall (China) Co. Ltd., Pall (Schweiz) GmbH, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, QHC Ireland Finance Limited, Radiometer, Radiometer Basel AG, Radiometer K.K., Radiometer Medical ApS, Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, SH Switzerland Finance Sarl, Sea-Bird Electronics Inc., SenDx Medical Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Sutron, Sybron Dental Specialties, TCIL Ireland Finance Ltd., Tektronix, Thomson Industries, Tianjin Bonna-Agela Technologies Co. Ltd., Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (Shanghai) Co. Ltd., Videojet Technologies Europe B.V., Videojet Technologies Inc., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, X-Rite Switzerland GmbH, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..

When was Danaher founded?

Danaher was founded in 1984.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

Where are Danaher's headquarters?

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at (202) 828-0850, via email at [email protected], or via fax at 202-828-0860.

This page was last updated on 1/25/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.